Soley Therapeutics is a science-first, tech-enabled biotechnology company that uses whole-cell sensing to translate cellular responses under stress and drug exposure into medicines. Leveraging proprietary imaging, automation, and computational analysis, they uncover how living cells decide to adapt, recover, or die to inform the discovery and development of first-in-class therapeutics. Based in South San Francisco, California, the company focuses on oncology and non-oncology complex diseases, aiming to accelerate translation from biology to clinic.
No recent deals for this company.